Showing results (271-280 of 282) with videos related to
Sort By:
Pageof 29
Cancer|April 15, 1981
Cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil in advanced prostatic cancer: a randomized trialH B Muss, V Howard, F Richards, et al.Cancer|August 11, 1991
Differences in the leucine aminopeptidase activity in extracts from human prostatic carcinoma and benign prostatic hyperplasiaR R Rackley, B Yang, T G Pretlow, et al.International Journal of Cancer|November 21, 1991
Tissue concentrations of prostate-specific antigen in prostatic carcinoma and benign prostatic hyperplasiaT G Pretlow, T P Pretlow, B Yang, et al.Journal of the National Cancer Institute|April 16, 1998
Altered expression of RET proto-oncogene product in prostatic intraepithelial neoplasia and prostate cancerD M Dawson, E G Lawrence, G T MacLennan, et al.The Prostate|October 12, 2000
Replication linkage study for prostate cancer susceptibility genesB K Suarez, J Lin, J S Witte, et al.The Journal of Urology|December 1, 1995
Prostate Cancer Clinical Guidelines Panel Summary report on the management of clinically localized prostate cancer. The American Urological AssociationR G Middleton, I M Thompson, M S Austenfeld, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 1999
Overexpression of ornithine decarboxylase in prostate cancer and prostatic fluid in humansR R Mohan, A Challa, S Gupta, et al.AJR. American Journal of Roentgenology|December 1, 1983
NMR scanning of the pelvis: initial experience with a 0.3 T systemP J Bryan, H E Butler, J P LiPuma, et al.Journal of the National Cancer Institute|March 3, 1993
Xenografts of primary human prostatic carcinomaT G Pretlow, S R Wolman, M A Micale, et al.Cancer Research|July 1, 1996
CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agarM Nagabhushan, C M Miller, T P Pretlow, et al.Pageof 29